Related Experiment Video
Updated: May 4, 2026

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
Published on: September 9, 2012
Changes in factor XIII level during pregnancy.
L T Sharief1, A S Lawrie, I J Mackie
1Institute of Women's Health, University College London, London, UK; Obstetrics and Gynaecology Department, Haemophilia centre and Thrombosis Unit, Royal Free Hospital NHS Foundation Trust, London, UK.
Pregnancy significantly reduces factor XIII (FXIII) activity, with levels decreasing throughout gestation. This study establishes new reference ranges for FXIII during pregnancy and postpartum, crucial for understanding haemostatic changes.
Area of Science:
- Obstetrics and Gynecology
- Hematology
- Clinical Chemistry
Background:
- Pregnancy induces significant haemostatic alterations, including rising clotting factors.
- Limited data exists on factor XIII (FXIII) level changes during pregnancy.
Purpose of the Study:
- To assess changes in plasma FXIII activity throughout normal pregnancy.
- To establish trimester-specific and immediate postnatal reference ranges for FXIII activity.
Main Methods:
- Cross-sectional study of 376 women with normal pregnancies.
- Plasma FXIII activity measured using a chromogenic assay on a CS-5100 analyser.
- Samples collected during the first, second, third trimesters, and immediate postnatal period, with a non-pregnant control group.
Main Results:
- Mean FXIII activity decreased progressively: first trimester (112 IU dL(-1)), second (96 IU dL(-1)), third (83 IU dL(-1)), and postnatal (90 IU dL(-1)).
- Significant reduction in mean FXIII activity observed in the second and third trimesters compared to the first trimester and controls (P < 0.0001).
- Postnatal FXIII levels were lower than the first trimester and control group.
Conclusions:
- This study provides essential reference ranges for FXIII activity during pregnancy and the early postpartum period.
- Normal pregnancy is associated with a significant decrease in FXIII activity, particularly in later trimesters.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Mitral Valve Prolapse III: Nursing Management
Venous Thrombosis IV: Nursing Management
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.

